Anika Therapeutics, Inc. (ANIK) Reports Improved Q4 EPS of $0.21

Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q4 EPS of $0.21, versus $0.10 reported last year. Revenue for the quarter came in at $18.4 million, versus $14.7 million reported last year.

For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Canterbury Park (CPHC) Misses Q2 EPS by 3c
• Optex Systems Holdings, Inc. (OPXS) Misses Q3 EPS by 2c